By: Sruthy Iype  Sep. 18, 2020

Dexur’s analysis of Medicare claims data showed that Entyvio was used in five times as many Crohn’s disease patients compared to Stelara in 2019. The analysis looked at the J code usage of the drugs (J3380/J3357) among Medicare patients who received treatment in hospital outpatient settings between Jan 2017 and Dec 2019. The analysis also looks at the average claims per patient data, which is a proxy for the number of injections / IV infusions / doses administered to a patient.

By: Parvathy Rajagopal  Sep. 18, 2020

Dexur’s analysis of medicare claims of hospitals within a 10-mile radius of Olympia, Washington showed that Capital Medical Center and Providence St. Peter Hospital had the best value outcomes over a 90 day episode for Hip & Knee replacement. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. Total cost of care data helps patients make appropriate choices and helps local ACOs make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 470: Major Joint Replacement or Reattachment of Lower Extremity without Major Complication or Comorbidity (MCC), to adjust for complications and comorbidities.

By: Sruthy Iype  Sep. 17, 2020

Dexur’s analysis of Medicare claims data showed that Keytruda was used in the treatment of a higher proportion of merkel cell carcinoma patients compared to Bavencio in 2019. The analysis looked at the J code usage of the drugs (J9271/J9023) among Medicare patients who received treatment in hospital outpatient settings between Jan 2018 and Dec 2019. The study also looks at the average claims per patient data, which is a proxy for the number of injections / IV infusions / doses administered to a patient.

By: Parvathy Rajagopal  Sep. 17, 2020

Dexur’s analysis of Medicare claims of hospitals within a 10-mile radius of Baton Rouge, LA, showed that Ochsner Medical Center - Baton Rouge, Our Lady of the Lake Regional Medical Center and Baton Rouge General had the best value outcomes over a 90-day episode for Sepsis. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days, including the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. The total cost of care data helps patients make appropriate choices and helps local ACOs like Louisiana Primary Care Accountable Care Organization, LLC, TP-ACO L.L.C., etc., make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 871: Septicemia or Severe Sepsis without MV >96 Hours with Major Complication or Comorbidity, to adjust for complications and comorbidities.

By: Sruthy Iype  Sep. 16, 2020

Dexur’s analysis of Medicare claims data showed a growth of almost 10 percent in the lung cancer share of Cyramza’s usage in 2019, as compared to 2018. The analysis looked at the J code usage of the drug (J9308) among Medicare patients who received treatment in hospital outpatient settings between Jan 2017 and Dec 2019. The study also looks at the average claims per patient data, which is a proxy for the number of injections / IV infusions / doses administered to a patient.

By: Parvathy Rajagopal  Sep. 16, 2020

Dexur’s analysis of Medicare claims of hospitals within a 10-mile radius of Hot Springs, Arkansas, showed that CHI St. Vincent Hot Springs and National Park Medical Center had the best value outcomes over a 90-day episode for Sepsis. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days, including the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. The total cost of care data helps patients make appropriate choices and helps local ACOs make appropriate referrals choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 871: Septicemia or Severe Sepsis without MV >96 Hours with Major Complication or Comorbidity, to adjust for complications and comorbidities.

By: Parvathy Rajagopal  Sep. 15, 2020

Dexur’s analysis of medicare claims of hospitals within a 10-mile radius of Lawton, Oklahoma, showed that Southwestern Medical Center and Comanche County Memorial Hospital had the best value outcomes over a 90 day episode for Hip & Knee replacement. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. Total cost of care data helps patients make appropriate choices and helps local ACOs make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 470: Major Joint Replacement or Reattachment of Lower Extremity without Major Complication or Comorbidity (MCC), to adjust for complications and comorbidities.

By: Parvathy Rajagopal  Sep. 15, 2020

Dexur’s analysis of medicare claims of hospitals within a 10-mile radius of Idaho Falls, Idaho showed that Mountain View Hospital and Eastern Idaho Regional Medical Center had the best value outcomes over a 90 day episode for Hip & Knee replacement. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. Total cost of care data helps patients make appropriate choices and helps local ACOs like Eastern Idaho Care Partners ACO LLC., make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 470: Major Joint Replacement or Reattachment of Lower Extremity without Major Complication or Comorbidity (MCC), to adjust for complications and comorbidities.

By: Sruthy Iype  Sep. 14, 2020

Dexur’s analysis of Medicare claims data showed that Velcade is used in three times as many multiple myeloma patients as compared to Kyprolis. The analysis was based on the J code usage of the drugs (J9041 /J9047) among Medicare patients who received treatment in hospital outpatient settings between Jan 2017 and Dec 2019. The analysis also looks at the average claims per patient data, which is a proxy for the number of injections / IV infusions / doses administered to a patient.

By: Parvathy Rajagopal  Sep. 14, 2020

Dexur’s analysis of medicare claims of hospitals within a 10-mile radius of Fort Smith, Arkansas, showed that Sparks Regional Medical Center and Mercy Hospital Fort Smith had the best value outcomes over a 90 day episode for Hip & Knee replacement. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. Total cost of care data helps patients make appropriate choices and helps local ACOs make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 470: Major Joint Replacement or Reattachment of Lower Extremity without Major Complication or Comorbidity (MCC), to adjust for complications and comorbidities.